Carregant...
The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials
OBJECTIVES: This meta-analysis aims to assess the clinical efficacy and safety of nemonoxacin in comparison with levofloxacin in treating community-acquired pneumonia (CAP). MATERIALS AND METHODS: The Pubmed, Embase, ClinicalTrials.gov., and the Cochrane databases were searched up to September 2018....
Guardat en:
| Publicat a: | Infect Drug Resist |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6388749/ https://ncbi.nlm.nih.gov/pubmed/30863126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S193233 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|